Singapore: Australia-based Allied Healthcare has marked a stronger sales with revenues up at 13 percent to $3.7 million ...
Singapore: Senator Kate Lundy, the Australian minister assisting for industry and innovation, has launched Australian ...
Singapore: Australian firm AtCor Medical, a developer and marketer of the SphygmoCor system that measures central aorti...
Singapore: ResMed, Australian developer, manufacturer and distributor of sleep and respiratory medical equipment, has l...
Singapore: Almirall granted commercial rights for Aclidinium in Australia and New Zealand for the treatment of chronic ...
Singapore: Viralytics' American Depository Receipts (ADRs) have commenced trading on OTCQX International. ADRs trade und...
Singapore: Allied Healthcare has lodged its Premarket Notification 510(k) Submission for CardioCel in the US. The FDA 51...
Singapore: Eminent AIDS researcher, Prof Joep Lange, died in the Malaysian Airlines flight MH17 crash on July 17 while h...
Australian drug delivery technology company Imugene has developed Linguet, a drug delivery technology platform, to impro...
I think there will be continuing of existing trends in 2013 as well. We expect to see ongoing growth in the point-of-car...
Singapore: World leaders and policy makers have gathered in Doha, Qatar, to discuss innovative solutions to the most pre...
Singapore: Australia's Mayne Pharma plans to acquire Kapanol and related assets in Australia from GlaxoSmithKline (GSK)....
Singapore: Patrys, a clinical stage biopharmaceutical company, received approval to progress its phase I/IIa PAT-SM6 mu...
Singapore: AtCor Medical, the developer and marketer of the SphygmoCor system that measures central blood pressures and ...
Singapore: Australia's biotechnology company, Starpharma has received a regulatory approval for the sale of its revoluti...
Singapore: Prima BioMed has appointed Dr Russell J Howard as a non-executive director with immediate effect. Dr Howard b...
Singapore: Melbourne-based Prana Biotechnology released an update on the Huntington Disease trial. The company reported ...
Singapore: Australia-based Starpharma is eligible to receive approximately $6 million cash in R&D tax incentives for...
